Sales and Marketing

Showing 15 posts of 11528 posts found.

FDA to expedite complex generic approvals to lower drug prices through competition

October 3, 2017 Manufacturing and Production, Sales and Marketing Donald Trump, Drug pricing, FDA, generics, pharma, pharmaceutical

In the midst of ongoing discussions over drug pricing, the FDA has announced plans to facilitate accelerated access to generic …

Overcoming real-world challenges to maximise the benefit of treatment for patients with multiple myeloma

October 2, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Takeda, multiple myeloma

Dr Antonio Palumbo, Distinguished Research Fellow Oncology, Takeda Pharmaceuticals addresses hwo far we’ve come in treating multiple myeloma, and how …

Collaboration brings forward potential broad flu cure

October 2, 2017 Research and Development, Sales and Marketing biotech, drugs, flu, influenza, pharma, pharmaceutical

A joint research effort between The Scripps Research Institute and Janssen has seen the development of a peptide that could …

FDA awards Roche priority review in HER2-positive breast cancer

October 2, 2017 Sales and Marketing Cancer, FDA, Herceptin, Perjeta, Roche, breast cancer, pharma, pharmaceutical

Roche has revealed that its monoclonal antibody Perjeta (pertuzumab) has been awarded priority review by the FDA as an adjuvant …

CureTech reclaims rare disease drug from Pfizer for $20 million

October 2, 2017 Sales and Marketing Clal Biotechnology, CureTech, Medivation, Pfizer, pharma, pharmaceutical

CureTech, a biotech firm owned by Clal Biotechnology Industries, is set to reclaim a drug it sold more than two …

Ablynx posts strong data on key drug, looks set for approval

October 2, 2017 Research and Development, Sales and Marketing Ablynx, biotech, drugs, pharma, pharmaceutical

In a major success for the European biotech industry, Ablynx has revealed that it had met the primary and secondary …

Lilly reveals major senior leadership reshuffle

October 2, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly, biotech, drugs, pharma, pharmaceutical

Eli Lilly revealed on 29 September that it would promote four staff members to senior staff positions, and two senior …

MSD pulls out of hep C space to Gilead’s relief

October 2, 2017 Sales and Marketing MSD, biotech, drugs, hepatitis C, pharma, pharmaceutical

MSD, known as Merck in North America, has announced that it will curtail its attempts to make an impact in …

Top Ten most popular articles on Pharmafile.com this week

September 29, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, EMA, FDA, HIV, J&J, JJ, Kevzara, Mylan, NICE, Sanofi, nash, top ten

It’s Friday, and it’s time for another round up of the most popular articles on pharmafile.com over the last seven …

Lilly receives FDA breast cancer pill approval, doubts remain

September 29, 2017 Medical Communications, Sales and Marketing Eli Lilly, Verzenio, biotech, drugs, pharma, pharmaceutical

Eli Lilly has received an important approval for its breast cancer treatment, Verzenio. The drug will be the third to …

Five more biosimilar-free years for AbbVie’s megablockbuster

September 28, 2017 Medical Communications, Sales and Marketing AbbVie, Amgen, Amjevita, Humira, biotech, drugs, pharma, pharmaceutical

Humira is the key drug for AbbVie, and one the company hopes it will be able to push into the …

Novo Nordisk Egypt promotes new General Manager

September 28, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novo Nordisk, biotech, drugs, pharma, pharmaceutical

Novo Nordisk Egypt has promoted Hassan Fahmi to become its new General Manager for operations within the company. Fahmi arrived …

Roche chalks up Swiss approval for multiple sclerosis drug Ocrevus

September 28, 2017 Sales and Marketing Ocrevus, Roche, multiple sclerosis, pharma, pharmaceutical

Roche has announced that its drug Ocrevus (ocrelizumab) has received marketing approval in Switzerland for the treatment of active relapsing …

Sanofi and Regeneron’s projected blockbuster gains EU approval

September 28, 2017 Sales and Marketing Dupixent, Regeneron, Sanofi, biotech, drugs, pharma, pharmaceutical

Sanofi and Regeneron have big hopes for their treatment Dupixent, and it has taken an important step towards reaching the …
The Gateway to Local Adoption Series

Latest content